Biotechnology
ACD Systems International Inc. has put a new level of control and convenience into photographers' hands with the release of ACDSee Pro 2, featuring next-generation workflow management and RAW processing functionality tested by thousands of professional p
05:00 Sep 11, 2007
in a single test. The Seeplex® 18-plex Respiratory Test robustly detects 11 different respiratory RNA viruses, 2 DNA viruses, and 5 pneumonia bacteria from samples including nasopharyngeal aspirates, nasopharyngeal swabs and bronchoalveolar lavage.
04:44 Sep 11, 2007
Ceapro Inc. , une entreprise de biotechnologie canadienne en pleine croissance, est heureuse d'annoncer la nomination de Monsieur Gilles Gagnon en tant que membre du conseil d'administration, fonction qu'il occupe à compter d'aujourd'hui. M. Gagnon, qui
04:34 Sep 11, 2007
Corcept Therapeutics Incorporated today announced that it has received notification from the Food and Drug Administration that the FDA has opened the Investigational New Drug application for CORLUX for the treatment of Cushing's Syndrome. CORLUX is a cor
04:00 Sep 11, 2007
Medistem Laboratories announced today that Thomas Ichim, Chief of Scientific Development, will participate in a mission organized by the Canadian Consulate and the Government of Alberta for promoting scientific interactions between the Arizona-based stem
03:10 Sep 11, 2007
CV Technologies Inc. has been served with Statements of Claim in two co-ordinated class actions commenced simultaneously in Ontario and Alberta against the Company and certain officers and directors and the Company's former auditors. The lawsuits seek ce
03:04 Sep 11, 2007
Micro Imaging Technology announced that its laser-based, microbial rapid identification system, the MIT 1000, is able to rapidly identify the life-threatening bacterial strain Methicillin Resistant Staphylococcus aureus .
03:00 Sep 11, 2007
Theratechnologies announced today that it has learned from the US Food and Drug Administration that, based on the information known today, the tesamorelin clinical development program is moving in the right direction.
02:34 Sep 11, 2007
Stellar Pharmaceuticals Inc., , a Canadian pharmaceutical developer and marketer of high quality, cost-effective products for select health care markets, today announced it has agreed to a settlement of its previously disclosed dispute with its European
02:34 Sep 11, 2007
Theratechnologies annonce aujourd'hui que la Food and Drug Administration aux Etats-Unis l'a informée, que sur base des informations connues à ce jour, le programme de développement clinique de la tésamoréline évolue de façon favorable.
02:34 Sep 11, 2007
Ceapro Inc. a Canadian growth-stage biotechnology company is delighted to announce that Gilles Gagnon, with 25 years experience in healthcare and pharmaceutical organizations, most recently as President and CEO of AEterna Zentaris, has joined the Board,
02:34 Sep 11, 2007
Enobia Pharma Inc, announced today that it raised $Cdn 40.1 Million in a Series B multi-tranche financing. The proceeds will be used primarily to fund the Company's novel hypophosphatasia drug development program through Phase 2 clinical trials. There is
02:34 Sep 11, 2007
Ceapro Inc. a Canadian growth-stage biotechnology company is delighted to announce that Gilles Gagnon, with 25 years experience in healthcare and pharmaceutical organizations, most recently as President and CEO of AEterna Zentaris, has joined the Board,
02:30 Sep 11, 2007
Theratechnologies announced today that it has learned from the US Food and Drug Administration that, based on the information known today, the tesamorelin clinical development program is moving in the right direction.
02:30 Sep 11, 2007
The latest study from pharmaceutical intelligence leader Cutting Edge Information is now accepting participants. 'Pharmaceutical Thought Leader Management 2008' is designed to benchmark fair-market value compensation for thought leaders in 20 different t
02:28 Sep 11, 2007
35462 - 35476 of 44966 Stories
<<
<
Next 15 Biotechnology
>
>>
Search News
Daily News
